Search

Your search keyword '"Freund's Adjuvant immunology"' showing total 50 results

Search Constraints

Start Over You searched for: Descriptor "Freund's Adjuvant immunology" Remove constraint Descriptor: "Freund's Adjuvant immunology" Publisher elsevier science Remove constraint Publisher: elsevier science
50 results on '"Freund's Adjuvant immunology"'

Search Results

1. Superior protection against paratuberculosis by a heterologous prime-boost immunization in a murine model.

2. Daphnetin inhibits spinal glial activation via Nrf2/HO-1/NF-κB signaling pathway and attenuates CFA-induced inflammatory pain.

3. Identification of the metabolites in normal and AA rat plasma, urine and feces after oral administration of Daphne genkwa flavonoids by LC-Q-TOF-MS spectrometry.

4. Effect on cellular recruitment and the innate immune response by combining saponin, monophosphoryl lipid-A and Incomplete Freund's Adjuvant with Leishmania (Viannia) braziliensis antigens for a vaccine formulation.

5. Thymulin treatment attenuates inflammatory pain by modulating spinal cellular and molecular signaling pathways.

6. Sandwich pair nanobodies, a potential tool for electrochemical immunosensing serum prostate-specific antigen with preferable specificity.

7. Levetiracetam mitigates lipopolysaccharide-induced JAK2/STAT3 and TLR4/MAPK signaling pathways activation in a rat model of adjuvant- induced arthritis.

8. Squalene containing solid lipid nanoparticles, a promising adjuvant system for yeast vaccines.

9. Chronic iron overload induces gender-dependent changes in iron homeostasis, lipid peroxidation and clinical course of experimental autoimmune encephalomyelitis.

10. The protective effects of curculigoside A on adjuvant-induced arthritis by inhibiting NF-кB/NLRP3 activation in rats.

11. Therapeutic effect of 7, 3'-dimethoxy hesperetin on adjuvant arthritis in rats through inhibiting JAK2-STAT3 signal pathway.

12. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment.

13. Early-life exposure to lipopolysaccharide reduces the severity of experimental autoimmune encephalomyelitis in adulthood and correlated with increased urine corticosterone and apoptotic CD4+ T cells.

14. Collagen-induced arthritis and related animal models: how much of their pathogenesis is auto-immune, how much is auto-inflammatory?

15. Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation.

16. The ability of human bispecific anti-idiotype antibody to elicit humoral and cellular immune responses in mice.

17. Activation of mu opioid receptor inhibits the excitatory glutamatergic transmission in the anterior cingulate cortex of the rats with peripheral inflammation.

18. Comparative study of the effects of aluminum adjuvants and Freund's incomplete adjuvant on the immune response to an Edwardsiella tarda major antigen.

19. Type I interferons as mediators of immune adjuvants for T- and B cell-dependent acquired immunity.

20. Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection.

21. Identification of potent biodegradable adjuvants that efficiently break self-tolerance--a key issue in the development of therapeutic vaccines.

22. The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams.

23. Synthesis and immunological evaluation of self-adjuvanting glycolipopeptide vaccine candidates.

24. Synergistic anti-hyperalgesia of electroacupuncture and low dose of celecoxib in monoarthritic rats: involvement of the cyclooxygenase activity in the spinal cord.

25. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant.

26. Modifications increasing the efficacy of recombinant vaccines; marked increase in antibody titers with moderately repetitive variants of a therapeutic allergy vaccine.

27. Immune response against grouper nervous necrosis virus by vaccination of virus-like particles.

28. Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation: An in vivo and in vitro study.

29. Low-dose intraperitoneal Freund's adjuvant: toxicity and immunogenicity in mice using an immunogen targeting amyloid-beta peptide.

30. Cold stress equally enhances in vivo pro-inflammatory cytokine gene expression in chicken lines divergently selected for antibody responses.

31. A synthetic gonadotropin-releasing hormone (GnRH) vaccine for control of fertility and hormone dependent diseases without any adjuvant.

32. Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity.

33. Vaccination with gp120-depleted HIV-1 plus immunostimulatory CpG oligodeoxynucleotides in incomplete Freund's adjuvant stimulates cellular and humoral immunity in rhesus macaques.

34. Induction of neuropeptide gene expression and blockade of retrograde transport in facial motor neurons following local peripheral nerve inflammation in severe combined immunodeficiency and BALB/C mice.

35. CpG DNA induces stronger immune responses with less toxicity than other adjuvants.

36. Development of recombinant ovalbumin-luteinizing hormone releasing hormone as a potential sterilization vaccine.

37. Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide.

38. Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses.

39. Delayed progression of murine AIDS in C57BL/6 mice pre-immunized with a highly antigenic 10-mer peptide encoded by the murine AIDS defective virus gag p12 gene.

40. Whole-killed gp120-depleted HIV-1 antigen in a murine model for prophylactic vaccination.

41. Production of highly potent horse antivenom against the Thai cobra (Naja kaouthia).

42. Kinetics, localization and cytokine profile of T cell responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins.

43. Specific and long-lasting suppression of rat adjuvant arthritis by low-dose Mycobacterium butyricum.

44. Immunological analysis of the protective responses to the chimeric synthetic peptide representing T- and B-cell epitopes from the fusion protein of measles virus.

45. Effect of Freund's adjuvants on guinea pigs infected with, or vaccinated against, Trichostrongylus colubriformis.

46. Antigen-specific T-cell activations distinguished by in vivo anti-CD4 antibody treatment.

47. Effect of apocynin on the induction of ulcerative lesions in rat skin injected with tubercle bacteria.

48. Effects of Freund's complete adjuvant and ovalbumin sensitization on the pharmacological reactivity of isolated guinea-pig trachea.

49. Characterization of the delayed hypersensitivity response to a protein antigen in the mouse--I. Kinetics of reactivity and sensitivity to classical immunosuppressants.

50. Immunity to Aeromonas salmonicida in coho salmon (Oncorhynchus kisutch) induced by modified Freund's complete adjuvant: its non-specific nature and the probable role of macrophages in the phenomenon.

Catalog

Books, media, physical & digital resources